John Theurer Cancer Center | Strategic Alliance Partners

Latest from John Theurer Cancer Center

Meet the New Chief: McCloskey Takes Helm at John Theurer Cancer Center’s Leukemia Division

October 15, 2020

Article

As James K. McCloskey II, MD, begins the next chapter of his career as chief of the Division of Leukemia at John Theurer Cancer Center at Hackensack University Medical Center.

Hackensack University Medical Center Urologists Offer Pioneering Clinical Trial to Study Nerve Recovery after Robotic Prostatectomy for Prostate Cancer

October 12, 2020

Article

Department of Urology uses bioregenerative medicine to improve erectile function and continence after robotic radical prostatectomy.

Dr. Vesole on the Advantages of CAR T-Cell Therapy in Multiple Myeloma

October 05, 2020

Video

David H. Vesole, MD, PhD, discusses the advantages of CAR T-cell therapy in multiple myeloma.

Dr. Goy on the Utility of NGS in Identifying Aggressive MCL Subtypes

October 01, 2020

Video

Andre Goy, MD, MS, discusses the utility of next-generation sequencing in identifying aggressive subtypes of mantle cell lymphoma.

Monoclonal Antibodies, ADCs, and CAR T Cells Invigorate the Myeloma Paradigm

September 29, 2020

Article

David H. Vesole, MD, PhD, discusses the evolution of multiple myeloma treatment, and explained how other BCMA-therapies are poised to impact clinical practice.

Dr. Leslie on the Development of CAR T-Cell Therapy in DLBCL and MCL

September 28, 2020

Video

Lori A. Leslie, MD, discusses developments in CAR T-cell therapy in diffuse large B-cell lymphoma and mantle cell lymphoma.